2019 Jun Merav Jacobson Bensky, Irit Ayalon-Dangur, Roi Ayalon-Dangur, Eviatar Naamany, Anat Gafter-Gvili, Gideon Koren, Shachaf Shiber
Anyone with a personal or family history of certain thyroid cancers, pancreatitis, or serious gastrointestinal disease sits outside the comfortable-experimentation zone these compounds occupy, since those conditions appeared in trial exclusion criteria for good reason
The landmark SURMOUNT-1 trial demonstrated that participants receiving the highest dose of tirzepatide lost up to 22.5% of their total body weight over 72 weeks
Our commitment to transparency includes publication of assay results, purity verification, identity confirmation, endotoxin testing, microbial screening, elemental impurity analysis and molecular mass verification
Results: Endotoxins Products passing endotoxin testing included Ocean Pharmaceutical and Hospira vial #2